# Vabb After Neoadjuvant Therapy to Avoid Surgery-pCR to Avoid Breast Surgery

> **NCT06281210** · NA · RECRUITING · sponsor: **European Institute of Oncology** · enrollment: 77 (estimated)

## Conditions studied

- Breast Cancer
- Triple Negative Breast Cancer
- HER2-positive Breast Cancer
- Neoadjuvant Chemotherapy

## Interventions

- **PROCEDURE:** Omission of surgical treatment

## Key facts

- **NCT ID:** NCT06281210
- **Lead sponsor:** European Institute of Oncology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-11
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 77 (ESTIMATED)
- **Last updated:** 2024-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06281210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06281210, "Vabb After Neoadjuvant Therapy to Avoid Surgery-pCR to Avoid Breast Surgery". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06281210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*